MY144608A - Insulinotropic peptide synthesis - Google Patents

Insulinotropic peptide synthesis

Info

Publication number
MY144608A
MY144608A MYPI20085211A MYPI20085211A MY144608A MY 144608 A MY144608 A MY 144608A MY PI20085211 A MYPI20085211 A MY PI20085211A MY PI20085211 A MYPI20085211 A MY PI20085211A MY 144608 A MY144608 A MY 144608A
Authority
MY
Malaysia
Prior art keywords
fragments
solid
solution phase
fragment
eases
Prior art date
Application number
MYPI20085211A
Other languages
English (en)
Inventor
Chen Lin
Han Yeun-Kwei
Christopher R Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MY144608A publication Critical patent/MY144608A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MYPI20085211A 2006-06-23 2007-06-19 Insulinotropic peptide synthesis MY144608A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23

Publications (1)

Publication Number Publication Date
MY144608A true MY144608A (en) 2011-10-14

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20085211A MY144608A (en) 2006-06-23 2007-06-19 Insulinotropic peptide synthesis

Country Status (33)

Country Link
US (2) US20080004429A1 (hr)
EP (1) EP2035451B1 (hr)
JP (1) JP4537495B2 (hr)
KR (1) KR101087859B1 (hr)
CN (1) CN101563364B (hr)
AR (1) AR061604A1 (hr)
AT (1) ATE466881T1 (hr)
AU (1) AU2007263043B2 (hr)
BR (1) BRPI0713575A2 (hr)
CA (1) CA2654610C (hr)
CL (1) CL2007001835A1 (hr)
CR (1) CR10463A (hr)
CY (1) CY1110186T1 (hr)
DE (1) DE602007006310D1 (hr)
DK (1) DK2035451T3 (hr)
EC (1) ECSP088999A (hr)
ES (1) ES2341588T3 (hr)
HR (1) HRP20100302T1 (hr)
IL (1) IL195421A0 (hr)
MA (1) MA30530B1 (hr)
MX (1) MX2008015935A (hr)
MY (1) MY144608A (hr)
NO (1) NO20084863L (hr)
NZ (1) NZ573093A (hr)
PL (1) PL2035451T3 (hr)
PT (1) PT2035451E (hr)
RS (1) RS51281B (hr)
RU (1) RU2448978C2 (hr)
SI (1) SI2035451T1 (hr)
TW (1) TWI331155B (hr)
UA (1) UA96602C2 (hr)
WO (1) WO2007147816A1 (hr)
ZA (1) ZA200810072B (hr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2205624T3 (da) 2007-10-27 2017-01-02 Corden Pharma Colorado Inc Insulinotropisk peptidsyntese under anvendelse af faststof- og opløsningsfasekombinationsteknikker
CA2707132A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
CA2759468A1 (en) * 2009-05-01 2010-11-04 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20110313131A1 (en) * 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
EP2788110B1 (en) * 2011-12-08 2018-10-17 Pentair Water Pool and Spa, Inc. Aquaculture system and method of operating a pump in such a system
CN104011064A (zh) 2011-12-29 2014-08-27 诺沃—诺迪斯克有限公司 包含非成蛋白质性的氨基酸的二肽
WO2014077802A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification method of a glp-1 analogue
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
KR20200130712A (ko) * 2018-03-09 2020-11-19 엔지펩 비.브이. 리라글루티드, 세마글루티드 및 glp-1의 화학-효소적 합성
EP3762408A1 (en) 2018-03-09 2021-01-13 Enzypep B.V. Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
CN112912390B (zh) * 2018-10-09 2023-12-15 北京费森尤斯卡比医药有限公司 Glp-1类似物的制备方法
TWI738260B (zh) 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
US20220324936A1 (en) * 2019-06-18 2022-10-13 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
WO1996032126A1 (en) * 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CN1495198A (zh) * 1998-12-07 2004-05-12 �о���Ӧ�ÿ�ѧЭ��ɷ����޹�˾ 胰高血糖素样肽-1的类似物
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
BRPI0713575A2 (pt) 2013-02-13
AU2007263043A1 (en) 2007-12-27
HRP20100302T1 (hr) 2010-06-30
CA2654610A1 (en) 2007-12-27
ECSP088999A (es) 2009-01-30
CN101563364A (zh) 2009-10-21
WO2007147816A1 (en) 2007-12-27
TWI331155B (en) 2010-10-01
KR20090023619A (ko) 2009-03-05
ATE466881T1 (de) 2010-05-15
AR061604A1 (es) 2008-09-10
CL2007001835A1 (es) 2008-03-14
JP2009541257A (ja) 2009-11-26
EP2035451A1 (en) 2009-03-18
RU2448978C2 (ru) 2012-04-27
TW200811195A (en) 2008-03-01
MA30530B1 (fr) 2009-06-01
JP4537495B2 (ja) 2010-09-01
CY1110186T1 (el) 2015-01-14
ES2341588T3 (es) 2010-06-22
NZ573093A (en) 2012-01-12
RS51281B (sr) 2010-12-31
EP2035451B1 (en) 2010-05-05
PT2035451E (pt) 2010-06-09
SI2035451T1 (sl) 2010-06-30
AU2007263043B2 (en) 2012-11-29
US20110213082A1 (en) 2011-09-01
US20080004429A1 (en) 2008-01-03
CR10463A (es) 2009-02-26
UA96602C2 (ru) 2011-11-25
CN101563364B (zh) 2014-04-02
KR101087859B1 (ko) 2011-11-30
IL195421A0 (en) 2011-08-01
PL2035451T3 (pl) 2010-08-31
MX2008015935A (es) 2009-01-13
DK2035451T3 (da) 2010-06-07
DE602007006310D1 (hr) 2010-06-17
CA2654610C (en) 2012-03-20
NO20084863L (no) 2009-01-22
RU2009101969A (ru) 2010-07-27
ZA200810072B (en) 2009-12-30

Similar Documents

Publication Publication Date Title
MY144608A (en) Insulinotropic peptide synthesis
MX2010006044A (es) Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
WO2010125079A3 (en) Insulinotropic peptide synthesis using solid and solution phase combination techniques
TR201816260T4 (tr) Wt1-antijen peptid konjugat aşı.
WO2006009902A3 (en) Non-natural amino acids
NZ597554A (en) Selective glucagon-like-peptide-2 (glp-2) analogues
GEP20146112B (en) Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and usage thereof
WO2009018126A3 (en) Collagen-related peptides and uses thereof
HK1088840A1 (en) Stable analogs of glp-1 glp-1
WO2008058016A2 (en) Ethoid-containing compounds, methods for preparing ethoid-containing compounds, and methods for use
Chen et al. Selective lysine modification of native peptides via aza-Michael addition
NZ612327A (en) Her2 binding peptides labelled with a 18f - containing organosilicon compound
MX2007013400A (es) Metodo de sintesis de peptidos.
WO2008113970A3 (en) Peptides
WO2007100358A3 (en) Convergent synthesis of proteins by kinetically controlled ligation
IL184080A (en) Synthesis of peptide t-20 using peptide intermediate fragments
MX2009012085A (es) Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos.
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
CN114450294A (zh) 具有mmp2抑制作用的多肽
WO2003062266A3 (en) Hybrid synthetic method for antimicrobial peptides
WO2007014992A3 (fr) Anticorps diriges contre le recepteur du ldl
GB0522295D0 (en) Peptides and uses thereof
WO2008029138A3 (en) Peptides and methods
Liao et al. Selective Coupling at the α-Amino Group of Cysteine Using Transfer Active-ester-condensation Technology to Synthesize a Linear Octadecapeptide